Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sandra Reilley"'
Autor:
Fang Liu, John A. Wagner, Eseng Lai, David L. Ebel, George Atiee, Victor Dishy, Sandra Reilley, Jane Royalty, John F. Paolini
Publikováno v:
The Journal of Clinical Pharmacology. 49:416-422
Niacin is an effective lipid-modifying therapy whose use has been limited by suboptimal tolerability. The adverse effect of flushing is due to prostaglandin D2 (PGD2)-mediated cutaneous vasodilation. Adjunctive treatment with the PGD2 receptor antago
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aa47b0fedf201af77c7b51ec983c90c
https://doi.org/10.1177/0091270009332246
https://doi.org/10.1177/0091270009332246
Autor:
Laurie Reynolds, Joseph M. Patti, Eric Wenzel, Beth Bennett, Sandra Reilley, Seth Hetherington
Publikováno v:
Antimicrobial Agents and Chemotherapy. 49:959-962
Tefibazumab (Aurexis) is a humanized monoclonal antibody being evaluated as adjunctive therapy for the treatment of Staphylococcus aureus infections. This open-label, dose escalation study evaluated the safety and pharmacokinetics of tefibazumab in 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8df677ca92e690bbdf0c4ae5417817e7
https://doi.org/10.1128/aac.49.3.959-962.2005
https://doi.org/10.1128/aac.49.3.959-962.2005